For those whom NAC was recommended per the NCCN guidelines (clinical stage ≥T2N0-3), the upregulation of TILs was even more widespread, as both conventional and memory subtypes of CD8+ T cells and total TILs were increased within the tumor tissue. This evidence concerns the gene CD8A and neoplasm.